CysLT<sub>1</sub>R downregulation reverses intracerebroventricular streptozotocin-induced memory impairment via modulation of neuroinflammation in mice.
第一作者:
Arijit,Ghosh
第一单位:
Department of Pharmacology, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu, China.
作者:
主题词
动物(Animals);抗哮喘药(Anti-Asthmatic Agents);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);钙结合蛋白质类(Calcium-Binding Proteins);色酮类(Chromones);细胞因子类(Cytokines);疾病模型, 动物(Disease Models, Animal);减量调节(Down-Regulation);脑炎(Encephalitis);绿色荧光蛋白质类(Green Fluorescent Proteins);HEK293细胞(HEK293 Cells);海马(Hippocampus);组蛋白类(Histones);人类(Humans);注射, 脑室内(Injections, Intraventricular);男(雄)性(Male);迷宫学习(Maze Learning);记忆障碍(Memory Disorders);小鼠(Mice);小鼠, 近交ICR(Mice, Inbred ICR);微丝蛋白质类(Microfilament Proteins);RNA, 信使(RNA, Messenger);RNA, 小分子干扰(RNA, Small Interfering);受体, 白三烯(Receptors, Leukotriene);信号传导(Signal Transduction);链脲菌素(Streptozocin);时间因素(Time Factors);转导, 遗传(Transduction, Genetic);转染(Transfection)
DOI
10.1016/j.pnpbp.2016.10.001
PMID
27720931
发布时间
2018-12-03
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文